Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Yerly

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Allergy and Clinical Immunology|November 21, 2017
Drug hypersensitivity: We need to do moreWerner J Pichler, Daniel Yerly
The Journal of Allergy and Clinical Immunology. in Practice|February 11, 2020
Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation testsLukas Jörg, Daniel Yerly, Werner Pichler
Current Opinion in Allergy and Clinical Immunology|June 16, 2018
Mechanisms leading to T-cell activation in drug hypersensitivityXiaoli Meng, Daniel Yerly, Dean J Naisbitt
Frontiers in Allergy|April 7, 2022
Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune SystemWerner J Pichler, Stephen Watkins, Daniel Yerly
Current Allergy and Asthma Reports|March 26, 2018
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and ManagementS Shahzad Mustafa, David Ostrov, Daniel Yerly
Allergy|July 3, 2023
Drug hypersensitivity and eosinophilia: The decisive role of p-i stimulationWerner J Pichler, Lester Thoo, Daniel Yerly
British Journal of Clinical Pharmacology|April 13, 2011
Delayed drug hypersensitivity: models of T-cell stimulationJacqueline Adam, Werner J Pichler, Daniel Yerly
Allergy|December 10, 2019
The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndromeLukas Jörg, Daniel Yerly, Arthur Helbling, et al.
Allergy|May 19, 2025
Legends of Allergy and Immunology: Werner PichlerLukas Joerg, Arthur Helbling, Oliver Hausmann, et al.
Clinical and Translational Allergy|December 9, 2020
Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)Lukas Jörg, Arthur Helbling, Daniel Yerly, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|November 21, 2017
Drug hypersensitivity: We need to do moreWerner J Pichler, Daniel Yerly
The Journal of Allergy and Clinical Immunology. in Practice|February 11, 2020
Multiple drug hypersensitivity syndrome (MDH) should not be diagnosed by drug provocation testsLukas Jörg, Daniel Yerly, Werner Pichler
Current Opinion in Allergy and Clinical Immunology|June 16, 2018
Mechanisms leading to T-cell activation in drug hypersensitivityXiaoli Meng, Daniel Yerly, Dean J Naisbitt
Frontiers in Allergy|April 7, 2022
Risk Assessment in Drug Hypersensitivity: Detecting Small Molecules Which Outsmart the Immune SystemWerner J Pichler, Stephen Watkins, Daniel Yerly
Current Allergy and Asthma Reports|March 26, 2018
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and ManagementS Shahzad Mustafa, David Ostrov, Daniel Yerly
Allergy|July 3, 2023
Drug hypersensitivity and eosinophilia: The decisive role of p-i stimulationWerner J Pichler, Lester Thoo, Daniel Yerly
British Journal of Clinical Pharmacology|April 13, 2011
Delayed drug hypersensitivity: models of T-cell stimulationJacqueline Adam, Werner J Pichler, Daniel Yerly
Allergy|December 10, 2019
The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndromeLukas Jörg, Daniel Yerly, Arthur Helbling, et al.
Allergy|May 19, 2025
Legends of Allergy and Immunology: Werner PichlerLukas Joerg, Arthur Helbling, Oliver Hausmann, et al.
Clinical and Translational Allergy|December 9, 2020
Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)Lukas Jörg, Arthur Helbling, Daniel Yerly, et al.
Pageof 5